Justin Arnall, PharmD, BCOP, Breanna Taylor, PharmD, BCOP, and Jeff Goff, RPh, MS, discuss how expanding IV iron indications across cardiology, oncology, and CKD are reshaping the pharmacist's role in formulary strategy, product stewardship, and patient identification.